The surgical management of primary invasive breast cancer

CA: A Cancer Journal for Clinicians

Volumn 45, Issue 5, 1995, Pages 279-288

  Moore, M P ^a   Kinne, D W ^a  

^a Columbia University School of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMAN; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0029117458     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/canjclin.45.5.279     Document Type: Article

References (65)

1. Cancer statistics: 1995
2. 1991 national survey of carcinoma of the breast by the Commission on Cancer
3. Long term follow up of breast cancer patients: The 30 year report
4. A long‐term follow‐up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma
5. Rationale and indications for limited surgery in breast cancer: Current data
6. A Danish randomized trial comparing breast‐preserving therapy with mastectomy in mammary carcinoma: Preliminary results
7. Eight‐year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
8. Ten‐year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer
9. Mastectomy versus radiotherapy as treatment for stage I‐II breast cancer: A prospective randomized trial at the National Cancer Institute
10. Regional differences in surgical management of breast cancer
11. Geographic variation in the use of breast‐conserving treatment for breast cancer
12. Geographic variation in the treatment of localized breast cancer
13. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast
14. Conservative treatment of early breast cancer: Long‐term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy
15. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B‐06: 10‐year pathologic and clinical prognostic determinants
16. The prognostic significance of late local recurrence after breast‐conserving therapy
17. Local recurrence after breast‐conserving surgery and radiotherapy: Frequency, time course, and prognosis
18. Significance of ipsilateral breast tumour recurrence after lumpectomy
19. Results of salvage surgery for mammary recurrence following breast‐conserving therapy
20. Time‐course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer
21. Predictors of local recurrence following conservative breast surgery and radiation therapy
22. Conservation therapy for breast cancers other than infiltrating ductal carcinoma
23. Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer
24. Infiltrating lobular carcinoma of the breast treated with segmental and modified radical mastectomy
25. Local recurrence after breast‐conserving surgery and radiotherapy
26. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast
27. Breast‐conserving therapy for macroscopically multiple cancers
28. Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers
29. Quadrantectomy versus lumpectomy for small size breast cancer
30. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively
31. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy
32. The second ten years: Long‐term risks of breast conservation in early breast cancer
33. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer
34. Conservative surgery and radiation therapy in breast carcinoma: Local recurrence and prognostic implications
35. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy
36. Mammary recurrences in women younger than forty
37. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data
38. Why are local recurrences (LR) after breast‐conserving surgery more frequent in young patients?
39. Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy
40. The presence of extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast
41. Adjuvant systemic chemotherapy and hormonal therapy: Effect on local recurrence in the conservatively treated breast cancer patient
42. The impact of breast‐conserving treatment and mastectomy on the quality of life of early‐stage breast cancer patients: A review
43. Axillary lymph node dissection for T1a breast carcinoma: Is it indicated?
44. Gamma‐probe guided localization of lymph nodes
45. Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer
46. Radical axillary dissection in the staging and treatment of breast cancer
47. Positron emission tomography with fluorine‐18‐deoxyglucose in the detection and staging of breast cancer
48. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2‐[F‐18]‐Fluoro‐2‐deoxy‐D‐glucose
49. Role of computed tomography in the staging of primary breast cancer
50. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer
51. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes
52. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter
53. Predictors of axillary lymph node metastases in patients with T1 breast cancer: A multivariate analysis
54. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma
55. Regional lymph node management in conservation treatment of early stage invasive breast carcinoma
56. Occult axillary lymph node metastases in node‐negative breast cancer
57. Distribution of axillary node metastases by level of invasion: An analysis of 539 cases
58. Role and extent of lymphadenectomy for early breast cancer
59. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer
60. Total axillary lymphadenectomy in the management of breast cancer
61. Regional nodal failure after conservative surgery and radiotherapy for early‐stage breast carcinoma
62. Breast cancer: Risk of axillary recurrence in node‐negative patients following partial dissection of the axilla
63. Axillary dissection in breast cancer: When, why, how much, and for how long: Another operation soon to be extinct?
64. Patients with early breast cancer benefit from effective axillary treatment